1. Home
  2. BTDR vs AMRX Comparison

BTDR vs AMRX Comparison

Compare BTDR & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BTDR

Bitdeer Technologies Group

HOLD

Current Price

$13.72

Market Cap

3.7B

Sector

Technology

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$17.04

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTDR
AMRX
Founded
2021
2002
Country
Singapore
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
4.0B
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
BTDR
AMRX
Price
$13.72
$17.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
5
Target Price
$22.70
$15.60
AVG Volume (30 Days)
10.6M
2.3M
Earning Date
05-11-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
157.89
EPS
N/A
0.19
Revenue
N/A
N/A
Revenue This Year
$72.51
$4.48
Revenue Next Year
$40.84
$7.13
P/E Ratio
N/A
$90.32
Revenue Growth
N/A
N/A
52 Week Low
$7.04
$7.67
52 Week High
$27.80
$17.86

Technical Indicators

Market Signals
Indicator
BTDR
AMRX
Relative Strength Index (RSI) 36.86 75.43
Support Level $10.03 $12.46
Resistance Level $15.68 N/A
Average True Range (ATR) 1.69 0.55
MACD -0.54 0.00
Stochastic Oscillator 6.44 66.67

Price Performance

Historical Comparison
BTDR
AMRX

About BTDR Bitdeer Technologies Group

Bitdeer Technologies Group is principally engaged in the provision of digital asset mining services. The Company does not conduct any substantive operations on its own but conducts its primary operations through its subsidiaries. Its majority business segments are: proprietary mining, cloud hash rate sharing and cloud hosting. The company operates five proprietary mining datacenters in the United States and Norway, Bhutan and Singapore.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: